BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17188294)

  • 1. Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2.
    Béguin PC; Belaidi E; Godin-Ribuot D; Lévy P; Ribuot C
    J Mol Cell Cardiol; 2007 Feb; 42(2):343-51. PubMed ID: 17188294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S; Tosaki A; Bagchi D; Maulik N; Das DK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.
    Weber NC; Toma O; Wolter JI; Obal D; Müllenheim J; Preckel B; Schlack W
    Br J Pharmacol; 2005 Jan; 144(1):123-32. PubMed ID: 15644876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
    Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
    Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia.
    Béguin PC; Joyeux-Faure M; Godin-Ribuot D; Lévy P; Ribuot C
    J Appl Physiol (1985); 2005 Sep; 99(3):1064-9. PubMed ID: 15879170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
    Kuno A; Critz SD; Cui L; Solodushko V; Yang XM; Krahn T; Albrecht B; Philipp S; Cohen MV; Downey JM
    J Mol Cell Cardiol; 2007 Sep; 43(3):262-71. PubMed ID: 17632123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury.
    Rakhit RD; Kabir AN; Mockridge JW; Saurin A; Marber MS
    Biochem Biophys Res Commun; 2001 Sep; 286(5):995-1002. PubMed ID: 11527399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism.
    Dana A; Skarli M; Papakrivopoulou J; Yellon DM
    Circ Res; 2000 May; 86(9):989-97. PubMed ID: 10807872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes.
    Saurin AT; Martin JL; Heads RJ; Foley C; Mockridge JW; Wright MJ; Wang Y; Marber MS
    FASEB J; 2000 Nov; 14(14):2237-46. PubMed ID: 11053245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
    Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
    Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of Ca2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells.
    Blanc A; Pandey NR; Srivastava AK
    Antioxid Redox Signal; 2004 Apr; 6(2):353-66. PubMed ID: 15025937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning.
    da Silva R; Grampp T; Pasch T; Schaub MC; Zaugg M
    Anesthesiology; 2004 Jan; 100(1):59-69. PubMed ID: 14695725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB activation and ischaemic preconditioning.
    Marais E; Genade S; Lochner A
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart.
    Baines CP; Wang L; Cohen MV; Downey JM
    J Mol Cell Cardiol; 1998 Feb; 30(2):383-92. PubMed ID: 9515015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent hypoxia protects the rat heart against ischemia/reperfusion injury by activating protein kinase C.
    Ding HL; Zhu HF; Dong JW; Zhu WZ; Zhou ZN
    Life Sci; 2004 Oct; 75(21):2587-603. PubMed ID: 15363663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
    Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
    Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.